Detalles de la búsqueda
1.
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
Br J Cancer
; 129(7): 1126-1133, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37542108
2.
The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologists.
Strahlenther Onkol
; 199(2): 115-120, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36598520
3.
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma.
Haematologica
; 108(12): 3347-3358, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37139600
4.
Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Haematologica
; 108(8): 2059-2066, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815361
5.
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.
Blood
; 133(8): 840-851, 2019 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30563875
6.
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.
Haematologica
; 106(8): 2224-2232, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32675228
7.
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials.
Eur J Nucl Med Mol Imaging
; 48(11): 3550-3559, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33928400
8.
Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma-data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin's Lymphoma Study Group).
Ann Hematol
; 100(4): 1031-1038, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33242101
9.
VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphoma.
Eur J Haematol
; 106(1): 100-104, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32997825
10.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet
; 394(10216): 2271-2281, 2019 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31868632
11.
Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential.
Cancer Immunol Immunother
; 69(8): 1535-1548, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32300857
12.
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.
Br J Haematol
; 182(6): 807-815, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29984825
13.
Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP.
Haematologica
; 108(10): 2844-2849, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815369
14.
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.
Br J Haematol
; 179(3): 410-420, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28990173
15.
MHC/Peptide-Specific Interaction of the Humoral Immune System: A New Category of Antibodies.
J Immunol
; 195(9): 4210-7, 2015 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26416277
16.
Suboptimal dosing of rituximab in male and female patients with DLBCL.
Blood
; 123(5): 640-6, 2014 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-24297867
17.
The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas.
Blood
; 124(5): 720-8, 2014 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-24939657
18.
Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation.
Blood
; 124(23): 3441-9, 2014 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-25270908
19.
Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.
Blood
; 123(26): 4027-36, 2014 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-24797300
20.
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study.
Ann Hematol
; 95(12): 1931-1942, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27696203